MTCP1
gene geneOn this page
Also known as P13MTCP1p8MTCP1TCL1C
Summary
MTCP1 (mature T cell proliferation 1, HGNC:7423) is a protein-coding gene on chromosome Xq28, encoding Protein p13 MTCP-1 (P56278). Enhances the phosphorylation and activation of AKT1 and AKT2.
This gene was identified by involvement in some t(X;14) translocations associated with mature T-cell proliferations. This region has a complex gene structure, with a common promoter and 5’ exon spliced to two different sets of 3’ exons that encode two different proteins. This gene represents the upstream 13 kDa protein that is a member of the TCL1 family. This protein may be involved in leukemogenesis.
Source: NCBI Gene 4515 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 4 total — 1 pathogenic, 2 likely-pathogenic
- MANE Select transcript:
NM_001018025
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:7423 |
| Approved symbol | MTCP1 |
| Name | mature T cell proliferation 1 |
| Location | Xq28 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | P13MTCP1, p8MTCP1, TCL1C |
| Ensembl gene | ENSG00000214827 |
| Ensembl biotype | protein_coding |
| OMIM | 300116 |
| Entrez | 4515 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 2 protein_coding_CDS_not_defined
ENST00000362018, ENST00000369476, ENST00000476116, ENST00000482244, ENST00000868540, ENST00000868541
RefSeq mRNA: 1 — MANE Select: NM_001018025
NM_001018025
CCDS: CCDS44027
Canonical transcript exons
ENST00000369476 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001450119 | 155064034 | 155065399 |
| ENSE00001622983 | 155065906 | 155066057 |
| ENSE00001746500 | 155070694 | 155071136 |
| ENSE00003652370 | 155065619 | 155065789 |
| ENSE00003652880 | 155065486 | 155065537 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 91.00.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0211 / max 6.6753, expressed in 8 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 201078 | 17.7624 | 1796 |
| 201079 | 1.9939 | 1255 |
| 201077 | 0.0873 | 23 |
| 201081 | 0.0211 | 8 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.00 | gold quality |
| adrenal tissue | UBERON:0018303 | 75.39 | gold quality |
| body of pancreas | UBERON:0001150 | 74.83 | gold quality |
| right testis | UBERON:0004534 | 73.37 | gold quality |
| right adrenal gland | UBERON:0001233 | 73.11 | gold quality |
| left testis | UBERON:0004533 | 72.74 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 72.65 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 72.62 | gold quality |
| left adrenal gland | UBERON:0001234 | 72.60 | gold quality |
| lower esophagus | UBERON:0013473 | 72.60 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 72.59 | gold quality |
| left ovary | UBERON:0002119 | 72.41 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 72.22 | gold quality |
| right ovary | UBERON:0002118 | 72.13 | gold quality |
| mucosa of stomach | UBERON:0001199 | 71.67 | gold quality |
| pancreas | UBERON:0001264 | 71.65 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 71.60 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 71.45 | gold quality |
| right lobe of liver | UBERON:0001114 | 71.10 | gold quality |
| body of stomach | UBERON:0001161 | 71.07 | gold quality |
| stromal cell of endometrium | CL:0002255 | 70.94 | gold quality |
| testis | UBERON:0000473 | 70.94 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 70.64 | gold quality |
| adrenal gland | UBERON:0002369 | 70.53 | gold quality |
| left uterine tube | UBERON:0001303 | 70.51 | gold quality |
| right atrium auricular region | UBERON:0006631 | 70.48 | gold quality |
| adrenal cortex | UBERON:0001235 | 70.39 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 70.37 | gold quality |
| transverse colon | UBERON:0001157 | 70.36 | gold quality |
| buccal mucosa cell | CL:0002336 | 70.28 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.73 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
121 targeting MTCP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-3912-5P | 99.95 | 66.11 | 925 |
| HSA-MIR-545-3P | 99.95 | 70.74 | 2783 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548BB-5P | 99.94 | 71.27 | 3509 |
| HSA-MIR-548C-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548D-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548H-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548I | 99.94 | 71.25 | 3481 |
| HSA-MIR-548J-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548O-5P | 99.94 | 71.24 | 3488 |
Literature-anchored findings (GeneRIF, showing 2)
- Transgenic mice overexpressing MTCP1 develop leukemias with a CD8 central memory phenotype in most cases. (PMID:17136114)
- Rare t(X;14)(q28;q32) translocation reveals link between MTCP1 and chronic lymphocytic leukemia. (PMID:34732719)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mtcp1 | ENSMUSG00000031200 |
| rattus_norvegicus | Cmc4 | ENSRNOG00000056435 |
Paralogs (2): TCL1A (ENSG00000100721), TCL1B (ENSG00000213231)
Protein
Protein identifiers
Protein p13 MTCP-1 — P56278 (reviewed: P56278)
Alternative names: Mature T-cell proliferation-1 type B1
All UniProt accessions (1): P56278
UniProt curated annotations — full annotation on UniProt →
Function. Enhances the phosphorylation and activation of AKT1 and AKT2.
Subunit / interactions. Interacts with AKT1 and AKT2 (via PH domain). Does not interact with AKT3.
Tissue specificity. Not found at a significant level in any tissue.
Disease relevance. Detected in T-cell leukemia bearing a t(X;14) translocation. Plays a key role in T-cell prolymphocytic leukemia.
Miscellaneous. Shares a non-coding 5’ exon with isoform 1 which is spliced to a different set of 3’ exons encoding an unrelated protein.
Similarity. Belongs to the TCL1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P56278-1 | 2, Long, Type B1, p13 MTCP1 | yes |
| P56277-1 | 1, Short, Type A, p8 MTCP1 |
RefSeq proteins (1): NP_001018025* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR004832 | TCL1_MTCP1 | Family |
| IPR036672 | TCL1_MTCP1_sf | Homologous_superfamily |
Pfam: PF01840
UniProt features (11 total): strand 8, chain 1, helix 1, turn 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 1A1X | X-RAY DIFFRACTION | 2 |
| 1QTT | SOLUTION NMR | |
| 1QTU | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P56278-F1 | 87.01 | 0.53 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 115 (showing top):
MORF_MTA1, BORCZUK_MALIGNANT_MESOTHELIOMA_UP, MORF_HDAC2, PUJANA_CHEK2_PCC_NETWORK, GOMF_KINASE_ACTIVATOR_ACTIVITY, CCTGTGA_MIR513, BROWNE_HCMV_INFECTION_14HR_DN, MORF_BUB3, MORF_RFC4, MORF_PRKDC, TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P, HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY, SCGGAAGY_ELK1_02, MGGAAGTG_GABP_B, GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY
GO Biological Process (1): intracellular signal transduction (GO:0035556)
GO Molecular Function (2): protein kinase binding (GO:0019901), protein serine/threonine kinase activator activity (GO:0043539)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 1 |
| signal transduction | 1 |
| kinase binding | 1 |
| protein serine/threonine kinase activity | 1 |
| protein kinase activator activity | 1 |
Protein interactions and networks
STRING
156 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MTCP1 | CPOX | P36551 | 703 |
| MTCP1 | CHCHD7 | Q9BUK0 | 644 |
| MTCP1 | FECH | P22830 | 555 |
| MTCP1 | ISCU | Q9H1K1 | 549 |
| MTCP1 | FXN | Q16595 | 547 |
| MTCP1 | MAPK13 | O15264 | 493 |
| MTCP1 | MAPK12 | P53778 | 491 |
| MTCP1 | ACO2 | Q99798 | 490 |
| MTCP1 | AKT1 | P31749 | 438 |
| MTCP1 | MAPK11 | Q15759 | 435 |
| MTCP1 | F5H3C5 | F5H3C5 | 411 |
| MTCP1 | SOD2 | P04179 | 411 |
| MTCP1 | CMC4 | P56277 | 410 |
| MTCP1 | SREBF1 | P36956 | 381 |
| MTCP1 | ATP5MG | O75964 | 345 |
IntAct
0 interactions, top by confidence:
BioGRID (7): MTCP1 (Two-hybrid), AKT1 (Affinity Capture-Western), MTCP1 (Two-hybrid), MTCP1 (Affinity Capture-Western), MTCP1 (Affinity Capture-RNA), MTCP1 (Affinity Capture-RNA), APP (Reconstituted Complex)
ESM2 similar proteins: A1XFV8, A7Y3E0, O12160, O41804, O70337, O70897, O70903, O89942, O91087, P04597, P04598, P04599, P05928, P05950, P05955, P0C1K5, P0C1K6, P0C1L9, P12519, P12520, P17284, P18805, P19555, P23428, P23429, P24737, P56278, P56279, P56280, P56840, P56841, P56844, P59636, P69725, P69726, P69727, P69728, Q1A248, Q25330, Q60945
Diamond homologs: O95988, P56278, P56280, Q60945, P56279
SIGNOR signaling
4 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MTCP1 | up-regulates | AKT | binding |
| MTCP1 | up-regulates | AKT1 | binding |
| MTCP1 | up-regulates | AKT2 | binding |
| MTCP1 | up-regulates | AKT3 | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
4 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 2 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 816415 | GRCh37/hg19 Xq28(chrX:154112019-154625699)x2 | Pathogenic |
| 564942 | GRCh37/hg19 Xq28(chrX:154110363-154417230)x2 | Likely pathogenic |
| 816417 | GRCh37/hg19 Xq28(chrX:154252722-154343784)x0 | Likely pathogenic |
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
700 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| X:155065690:A:G | W69R | 0.994 |
| X:155065690:A:T | W69R | 0.994 |
| X:155065688:C:A | W69C | 0.993 |
| X:155065688:C:G | W69C | 0.993 |
| X:155065640:C:A | W85C | 0.992 |
| X:155065640:C:G | W85C | 0.992 |
| X:155065642:A:G | W85R | 0.991 |
| X:155065642:A:T | W85R | 0.991 |
| X:155065926:A:G | W29R | 0.990 |
| X:155065926:A:T | W29R | 0.990 |
| X:155065943:T:A | D23V | 0.990 |
| X:155065950:A:C | Y21D | 0.989 |
| X:155065689:C:G | W69S | 0.988 |
| X:155065924:C:A | W29C | 0.987 |
| X:155065924:C:G | W29C | 0.987 |
| X:155065512:A:T | L101H | 0.985 |
| X:155065764:A:T | V44D | 0.985 |
| X:155065641:C:G | W85S | 0.984 |
| X:155065944:C:G | D23H | 0.984 |
| X:155065512:A:G | L101P | 0.982 |
| X:155065518:A:G | L99P | 0.982 |
| X:155065659:T:A | D79V | 0.982 |
| X:155065666:A:G | Y77H | 0.982 |
| X:155065942:G:C | D23E | 0.982 |
| X:155065942:G:T | D23E | 0.982 |
| X:155065665:T:G | Y77S | 0.981 |
| X:155065666:A:C | Y77D | 0.981 |
| X:155065950:A:T | Y21N | 0.979 |
| X:155065973:A:G | L13P | 0.978 |
| X:155065973:A:T | L13H | 0.977 |
dbSNP variants (sampled 300 via entrez): RS1000285506 (X:155070923 A>G), RS1003621099 (X:155064347 G>T), RS1003913027 (X:155064867 A>C), RS1004271514 (X:155065139 T>C), RS1005496711 (X:155072163 A>C), RS1008812549 (X:155066925 A>G), RS1008842176 (X:155066257 T>C), RS1009200289 (X:155067052 C>T), RS1009503000 (X:155067638 T>C), RS1010516727 (X:155070832 G>A,T), RS1010880059 (X:155063840 A>G), RS1011182782 (X:155064287 T>C), RS1013283451 (X:155069017 T>C), RS1014313603 (X:155071745 C>T), RS1014691787 (X:155065178 T>C)
Disease associations
OMIM: gene MIM:300116 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| pirinixic acid | increases activity, increases expression, affects binding | 1 |
| cobaltous chloride | decreases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| 2,3-bis(3’-hydroxybenzyl)butyrolactone | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Coumestrol | increases expression, affects cotreatment | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Vincristine | decreases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
| Chlorodiphenyl (54% Chlorine) | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.